Free Trial

Barings Corporate Investors (NYSE:MCI) Sees Large Growth in Short Interest

Barings Corporate Investors logo with Finance background

Barings Corporate Investors (NYSE:MCI - Get Free Report) was the recipient of a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 28,300 shares, a growth of 97.9% from the May 15th total of 14,300 shares. Based on an average daily trading volume, of 37,300 shares, the short-interest ratio is currently 0.8 days. Approximately 0.1% of the company's stock are short sold.

Insider Buying and Selling

In other news, insider Edward P. Grace III sold 10,000 shares of the business's stock in a transaction dated Tuesday, April 1st. The shares were sold at an average price of $22.71, for a total value of $227,100.00. Following the completion of the sale, the insider now owns 10,000 shares of the company's stock, valued at approximately $227,100. The trade was a 50.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.08% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Barings Corporate Investors

Institutional investors have recently modified their holdings of the business. GHP Investment Advisors Inc. bought a new stake in Barings Corporate Investors in the 1st quarter valued at about $25,000. Jones Financial Companies Lllp lifted its holdings in Barings Corporate Investors by 112.4% in the fourth quarter. Jones Financial Companies Lllp now owns 2,765 shares of the financial services provider's stock worth $56,000 after purchasing an additional 1,463 shares during the period. StoneX Group Inc. bought a new position in shares of Barings Corporate Investors in the fourth quarter valued at approximately $204,000. Fiduciary Trust Co acquired a new position in shares of Barings Corporate Investors during the fourth quarter valued at approximately $204,000. Finally, Sanctuary Advisors LLC bought a new stake in Barings Corporate Investors during the fourth quarter worth approximately $206,000.

Barings Corporate Investors Stock Down 0.7%

Barings Corporate Investors stock traded down $0.16 during midday trading on Tuesday, hitting $20.91. The stock had a trading volume of 17,277 shares, compared to its average volume of 36,454. The business has a fifty day moving average price of $20.27 and a 200 day moving average price of $20.67. Barings Corporate Investors has a 12 month low of $16.91 and a 12 month high of $25.24.

Barings Corporate Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 13th. Investors of record on Friday, May 30th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 7.65%. The ex-dividend date was Friday, May 30th.

Barings Corporate Investors Company Profile

(Get Free Report)

Babson Capital Corporate Investors trust is a closed ended fixed income mutual fund launched and managed by Barings LLC. It invests in fixed income markets of the United States. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in a portfolio of privately placed, below-investment grade, long term corporate debt obligations.

See Also

Should You Invest $1,000 in Barings Corporate Investors Right Now?

Before you consider Barings Corporate Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Barings Corporate Investors wasn't on the list.

While Barings Corporate Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines